T. Mürdter

Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

T. Fehm, H. Brauch, M. Eichelbaum, 2011, Clinical pharmacology and therapeutics.

Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry.

U. Hofmann, P. Dreger, M. Schwab, 2001, Clinical chemistry.

Decomposition of the telomere-targeting agent BRACO19 in physiological media results in products with decreased inhibitory potential.

U. Klotz, E. Kleideiter, K. Piotrowska, 2008, International journal of pharmaceutics.

Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high–pressure liquid chromatography–electrospray ionization tandem mass spectrometry

U. Hofmann, M. Schwab, T. Mürdter, 2005, Journal of Inherited Metabolic Disease.

Genetic Influences on the Pharmacokinetics of Orally and Intravenously Administered Digoxin as Exhibited by Monozygotic Twins

U. Hofmann, M. Eichelbaum, A. Busjahn, 2009, Clinical pharmacology and therapeutics.